Condition: Hearing Loss, Adult-Onset · Hearing Aid · Sponsor: Archean Technologies
The goal of this clinical trial is the evaluation of performances, clinical benefits and safety of the 'Audiocap' connected hearing rehabilitation device for improving audibility in hearing-impaired people. The main question it aims to answer is to demonstrate, after one month's use of the Audiocap connected hearing aid, that the audiological gain for the patient is better than with a placebo hearing aid. Placebo hearing aid is a Audiocap connected hearing aid with a 'NONE' setting (flat frequency response for the patient (equivalent to not wearing hearing aid). Participants will be first-time hearing aid users, eligible for hearing aid fitting, and adults according to French legislation (18 years and older).
This description comes directly from the study's public registry record.
Sixtine Marié · +33 (0)6 23 83 22 81 · smarie@archean.tech
Always discuss trial participation with your own doctor first.
| Hôpital Edouard Herriot | Lyon, France, France | Not Yet Recruiting |
| Clinique de l'Oreille | Paris, France, France | Not Yet Recruiting |
| Hôpital Lariboisière (APHP) | Paris, France, France | Not Yet Recruiting |
| Clinique Rive-Gauche | Toulouse, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07252492